Pfizer asks FDA to greenlight new omicron booster shots, which could arrive this fall

By NPR
| August 23, 2022

Pfizer and BioNTech have asked the FDA to authorize an updated version of their COVID-19 vaccine — this one designed specifically to target the omicron subvariants that are dominant in the U.S.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...